Hubbard Cristin, EVP and Chief Commercial Officer at BioMarin Pharmaceutical Inc. ($BMRN), sold shares once on the open market in the last year, totaling about $18,000. Her most recent sale occurred on May 2, 2025. This places her 11,093rd among 11,678 insiders in our database by sale value, well below the average of $8.6 million across about 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Common Stock | 15410 | $0.00 | 46,035.0000 | 196,893,000 | 50.32% | 0.01% |
| March 17, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | F | Common Stock | 1245 | $56.05 | 44,790.0000 | 196,893,000 | 2.70% | 0.00% |
| March 16, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Stock Option (Right to Buy Common Stock) | 36680 | $0.00 | 36,680.0000 | 196,893,000 | 9999.99% | 0.02% |
| Oct. 31, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Common Stock | 80 | $45.54 | 30,625.0000 | 196,893,000 | 0.26% | 0.00% |
| May 20, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | F | Common Stock | 2155 | $59.93 | 30,545.0000 | 196,708,000 | 6.59% | 0.00% |
| May 2, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | S | Common Stock | 273 | $64.92 | 32,700.0000 | 196,708,000 | 0.83% | 0.00% |
| April 30, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Common Stock | 273 | $54.14 | 32,973.0000 | 196,708,000 | 0.83% | 0.00% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Stock Option (Right to Buy Common Stock) | 30880 | $0.00 | 30,880.0000 | 196,708,000 | 9999.99% | 0.02% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Common Stock | 13310 | $0.00 | 32,700.0000 | 196,708,000 | 68.64% | 0.01% |
| May 20, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Common Stock | 14690 | $0.00 | 14,690.0000 | 191,595,000 | 9999.99% | 0.01% |
| May 20, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Common Stock | 4700 | $0.00 | 19,390.0000 | 191,595,000 | 31.99% | 0.00% |
| May 20, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hubbard Cristin | EVP, Chief Commercial Officer | A | Stock Option (Right to Buy Common Stock) | 33520 | $0.00 | 33,520.0000 | 191,595,000 | 9999.99% | 0.02% |